Inspire Medical falls on slower-than-expected sleep apnea device launch

Inspire Medical Systems

11/02/2025 15:34

** Sleep apnea device maker Inspire Medical Systems' shares
 INSP.N   fall 2.9% to $175.72 in morning trade
    ** Co late on Monday reported Q4 adj EPS of $1.15, above
Wall Street est of 73 cents - data compiled by LSEG 
    ** INSP said they have "made steady progress" toward the
full launch of sleep apnea device Inspire V during Q4 
    ** Wells Fargo says the launch is slower than expected due
to hurdles at its U.S and Mexico manufacturing plants 
    ** Scaling up production on a new U.S. line takes time, as
management aims to minimize disruption to production of the
older device Inspire IV while producing Inspire V, brokerage
says
    ** Brokerage says a civil investigation by the U.S. justice
department related to allegations of false information about
co's devices submitted to the agency might hurt the stock 
    ** Brokerages Truist, Morgan Stanley and Wells Fargo cut
their PTs on INSP
    ** Stock was down 1.3% in 2024

    

 (Reporting by Padmanabhan Ananthan)
 ((Padmanabhan.Ananthan@thomsonreuters.com;))